You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 5, May 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (48)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Surgery
 •Radionuclide Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relative Contributions of Technetium Tc 99m Sestamibi Scintigraphy, Intraoperative Gamma Probe Detection, and the Rapid Parathyroid Hormone Assay to the Surgical Management of Hyperparathyroidism

Alan P. B. Dackiw, MD, PhD; Jeffrey J. Sussman, MD; Herbert A. Fritsche, Jr, PhD; Ebrahim S. Delpassand, MD; Pam Stanford, RN; Ana Hoff, MD; Robert F. Gagel, MD; Douglas B. Evans, MD; Jeffrey E. Lee, MD

Arch Surg. 2000;135:550-557.

Hypothesis  Technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay have been used to permit a directed operation in patients with hyperparathyroidism. We hypothesized that the coordinated use of these techniques might be particularly useful in patients who require a second operation for hyperparathyroidism.

Design  Retrospective analysis was performed to determine the specific contribution of these technologies to the surgical management of patients with hyperparathyroidism who underwent evaluation by at least 2 of these techniques between April 1996 and October 1999.

Setting  Patients were evaluated and treated by an endocrine tumor surgery group within a tertiary care referral center.

Patients  Coordinated application of 99mTc-sestamibi scintigraphy, intraoperative gamma probe detection, and/or the rapid parathyroid hormone assay was performed in 32 patients.

Results  Twenty-eight of 32 patients had primary hyperparathyroidism, 3 had multiple endocrine neoplasia type 1, and 1 had secondary hyperparathyroidism. The surgical procedure was an initial cervical exploration in 19 and a second operative procedure in 13. Parathyroidectomy was successful in all patients. A directed anatomic operation was performed in 24 patients, including 11 patients who underwent second operative procedures and 9 patients who underwent minimally invasive procedures under local anesthesia. A directed operation was facilitated by sestamibi scan in 22 of 24 patients, intraoperative gamma probe detection in 5 of 23 patients, and the rapid parathyroid hormone assay in 15 of 15 patients.

Conclusions  Coordinated application of 99mTc-sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay allows for successful directed reoperative parathyroidectomy; a minimally invasive procedure may be performed in selected patients.


From the Departments of Surgical Oncology (Section of Endocrine Tumor Surgery), Research Laboratory Medicine, Nuclear Medicine, and Medical Specialties (Section of Endocrine Neoplasia and Hormonal Disorders), The University of Texas M. D. Anderson Cancer Center, Houston; and the Division of Surgical Oncology, University of Cincinnati Medical Center, Cincinnati, Ohio.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(5):609-610.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Hubbard et al.
Arch Surg 2006;141:235-239.
ABSTRACT | FULL TEXT  

Rapid Intraoperative Immunoassay of Parathyroid Hormone and Other Hormones: A New Paradigm for Point-of-Care Testing
Sokoll et al.
Clin. Chem. 2004;50:1126-1135.
ABSTRACT | FULL TEXT  

An Algorithm to Maximize Use of Minimally Invasive Parathyroidectomy
Quiros et al.
Arch Surg 2004;139:501-507.
ABSTRACT | FULL TEXT  

Multiple-Gland Disease in Primary Hyperparathyroidism: A Function of Operative Approach?
Lee and Norton
Arch Surg 2002;137:896-900.
ABSTRACT | FULL TEXT  

Modern Parathyroid Surgery: A Cost-benefit Analysis of Localizing Strategies
Fahy et al.
Arch Surg 2002;137:917-923.
ABSTRACT | FULL TEXT  

Intraoperative radioguided thoracoscopic removal of ectopic parathyroid adenoma
Ott et al.
Ann. Thorac. Surg. 2001;72:1758-1760.
ABSTRACT | FULL TEXT  

Evaluation of the Performance and Clinical Impact of a Rapid Intraoperative Parathyroid Hormone Assay in Conjunction with Preoperative Imaging and Concise Parathyroidectomy
Johnson et al.
Clin. Chem. 2001;47:919-925.
ABSTRACT | FULL TEXT  

Use of Intraoperative Parathyroid Hormone Measurement Does Not Improve Success of Bilateral Neck Exploration for Hyperparathyroidism
Starr et al.
Arch Surg 2001;136:536-542.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.